Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 3
1997 1
1998 3
1999 1
2000 2
2001 9
2002 4
2003 2
2004 5
2005 4
2006 5
2007 2
2008 3
2009 2
2010 5
2011 7
2012 9
2013 17
2014 4
2015 3
2016 14
2017 16
2018 12
2019 11
2020 14
2021 8
2022 2
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 29046291

153 results
Results by year
Filters applied: . Clear all
Page 1
Diabetic Kidney Disease.
Tong L, Adler SG. Tong L, et al. Clin J Am Soc Nephrol. 2018 Feb 7;13(2):335-338. doi: 10.2215/CJN.04650417. Epub 2017 Oct 18. Clin J Am Soc Nephrol. 2018. PMID: 29046291 Free PMC article. No abstract available.
Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
Pugliese G, Penno G, Natali A, Barutta F, Di Paolo S, Reboldi G, Gesualdo L, De Nicola L; Italian Diabetes Society and the Italian Society of Nephrology. Pugliese G, et al. Nutr Metab Cardiovasc Dis. 2019 Nov;29(11):1127-1150. doi: 10.1016/j.numecd.2019.07.017. Epub 2019 Oct 2. Nutr Metab Cardiovasc Dis. 2019. PMID: 31586514 Review.
GLP-1 Receptor Agonists in Diabetic Kidney Disease.
Michos ED, Tuttle KR. Michos ED, et al. Clin J Am Soc Nephrol. 2021 Oct;16(10):1578-1580. doi: 10.2215/CJN.18771220. Epub 2021 Apr 13. Clin J Am Soc Nephrol. 2021. PMID: 33849933 No abstract available.
SGLT2 Inhibitors and the Diabetic Kidney.
Fioretto P, Zambon A, Rossato M, Busetto L, Vettor R. Fioretto P, et al. Diabetes Care. 2016 Aug;39 Suppl 2:S165-71. doi: 10.2337/dcS15-3006. Diabetes Care. 2016. PMID: 27440829
Transforming the Care of Patients with Diabetic Kidney Disease.
Brosius FC, Cherney D, Gee PO, Harris RC, Kliger AS, Tuttle KR, Quaggin SE; DKD-Collaborative ASN Taskforce. Brosius FC, et al. Clin J Am Soc Nephrol. 2021 Oct;16(10):1590-1600. doi: 10.2215/CJN.18641120. Epub 2021 Jun 8. Clin J Am Soc Nephrol. 2021. PMID: 34103350 Review.
Analysis from the EMPA-REG OUTCOME® trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamics.
Mayer GJ, Wanner C, Weir MR, Inzucchi SE, Koitka-Weber A, Hantel S, von Eynatten M, Zinman B, Cherney DZI. Mayer GJ, et al. Kidney Int. 2019 Aug;96(2):489-504. doi: 10.1016/j.kint.2019.02.033. Epub 2019 Mar 21. Kidney Int. 2019. PMID: 31142441 Clinical Trial.
153 results